RE:Merck (MRK) CEO itching to make acquisition deals in pharma
Gotta love this kinda headline. This just ups the ante in the industry and certainly of Merck competitors to step up their own acquisition programs... which inherently pushes up the value of prime target drugs or companies in their entirety.
Either way, this just keeps getting better by the day. PLI actual valuation is chasing a rising prospective / comparative valuation ! chew on that ! :-)